1. Home
  2. ATAI vs AOSL Comparison

ATAI vs AOSL Comparison

Compare ATAI & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • AOSL
  • Stock Information
  • Founded
  • ATAI 2018
  • AOSL 2000
  • Country
  • ATAI Netherlands
  • AOSL United States
  • Employees
  • ATAI N/A
  • AOSL N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • AOSL Semiconductors
  • Sector
  • ATAI Health Care
  • AOSL Technology
  • Exchange
  • ATAI Nasdaq
  • AOSL Nasdaq
  • Market Cap
  • ATAI 1.1B
  • AOSL 940.9M
  • IPO Year
  • ATAI 2021
  • AOSL 2010
  • Fundamental
  • Price
  • ATAI $5.88
  • AOSL $27.78
  • Analyst Decision
  • ATAI Strong Buy
  • AOSL Strong Buy
  • Analyst Count
  • ATAI 5
  • AOSL 3
  • Target Price
  • ATAI $14.00
  • AOSL $32.00
  • AVG Volume (30 Days)
  • ATAI 7.1M
  • AOSL 245.3K
  • Earning Date
  • ATAI 11-14-2025
  • AOSL 11-05-2025
  • Dividend Yield
  • ATAI N/A
  • AOSL N/A
  • EPS Growth
  • ATAI N/A
  • AOSL N/A
  • EPS
  • ATAI N/A
  • AOSL N/A
  • Revenue
  • ATAI $2,309,000.00
  • AOSL $696,162,000.00
  • Revenue This Year
  • ATAI $736.04
  • AOSL $4.57
  • Revenue Next Year
  • ATAI N/A
  • AOSL $7.67
  • P/E Ratio
  • ATAI N/A
  • AOSL N/A
  • Revenue Growth
  • ATAI 510.85
  • AOSL 5.92
  • 52 Week Low
  • ATAI $1.04
  • AOSL $15.90
  • 52 Week High
  • ATAI $6.75
  • AOSL $53.29
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.01
  • AOSL 44.56
  • Support Level
  • ATAI $5.50
  • AOSL $27.80
  • Resistance Level
  • ATAI $6.23
  • AOSL $31.38
  • Average True Range (ATR)
  • ATAI 0.46
  • AOSL 1.45
  • MACD
  • ATAI -0.06
  • AOSL -0.28
  • Stochastic Oscillator
  • ATAI 26.71
  • AOSL 0.96

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

Share on Social Networks: